Q4 2016 Holdings
Filed 2017-02-10 | 12 holdings | $123.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals | Common Stock | 699374302 | $40.0K | 2,600,410 | 32.5% |
| Juno Therapeutics | Common Stock | 48205A109 | $23.2K | 1,229,512 | 18.8% |
| Egalet | Common Stock | 28226B104 | $22.1K | 2,889,926 | 17.9% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $17.6K | 822,175 | 14.3% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $6.8K | 1,145,890 | 5.5% |
| Cidara Therapeutics | Common Stock | 171757107 | $5.1K | 495,050 | 4.2% |
| Essa Pharma | Common Stock | 29668H104 | $3.7K | 1,696,969 | 3.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $2.4K | 1,697,384 | 1.9% |
| Editas Medicine(EDIT) | Common Stock | 28106W103 | $1.1K | 66,162 | 0.9% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $644 | 223,457 | 0.5% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $522 | 301,477 | 0.4% |
| Proteon Therapeutics | Common Stock | 74371L109 | $0 | 0 | 0.0% |